Related Experiment Video
Updated: Feb 11, 2026

Cone-Enriched Cultures from the Retina of Chicken Embryos to Study Rod to Cone Cellular Interactions
Published on: March 20, 2021
Primary Rod and Cone Degeneration Is Prevented by HDAC Inhibition
Dragana Trifunović1, Eleni Petridou2, Antonella Comitato3
1Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany. dragana.trifunovic@uni-tuebingen.de.
Abstract:
Photoreceptor cell death in inherited retinal degeneration is accompanied by over-activation of histone deacetylases (HDAC). Excessive HDAC activity is found both in primary rod degeneration (such as in the rd10 mouse) and in primary cone death, including the cone photoreceptor function loss 1 (cpfl1) mouse. We evaluated the potential of pharmacological HDAC inhibition to prevent photoreceptor degeneration in primary rod and cone degeneration. We show that a single in vivo treatment of cpfl1 mice with the HDAC inhibitor trichostatin A (TSA) resulted in a significant protection of cpfl1 mutant cones. Similarly, HDAC inhibition with the clinically approved HDAC inhibitor vorinostat (SAHA) resulted in a significant improvement of rod survival in rd10 retinal explant cultures. Altogether, these results highlight the feasibility of targeted neuroprotection in vivo and create hope to maintain vision in patients suffering from both rod and cone dystrophies.
Insights
Histone deacetylase (HDAC) over-activation drives photoreceptor cell death in inherited retinal diseases. Inhibiting HDAC with drugs like trichostatin A and vorinostat shows promise for protecting rod and cone cells, potentially preserving vision.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Inherited retinal degeneration involves photoreceptor cell death.
- Over-activation of histone deacetylases (HDAC) is a common feature in both rod and cone photoreceptor degeneration.
- Specific mouse models, rd10 for rod degeneration and cpfl1 for cone degeneration, exhibit excessive HDAC activity.
Purpose of the Study:
- To evaluate the potential of pharmacological HDAC inhibition for preventing photoreceptor degeneration.
- To assess the efficacy of HDAC inhibitors in models of primary rod and cone degeneration.
Main Methods:
- In vivo treatment of cpfl1 mice with trichostatin A (TSA).
- Treatment of rd10 retinal explant cultures with vorinostat (SAHA).
- Assessment of photoreceptor survival and protection following HDAC inhibition.
Main Results:
- A single in vivo TSA treatment significantly protected cone photoreceptors in cpfl1 mice.
- HDAC inhibition with vorinostat significantly improved rod photoreceptor survival in rd10 retinal explant cultures.
- Pharmacological HDAC inhibition demonstrates neuroprotective effects in models of retinal degeneration.
Conclusions:
- Targeted neuroprotection via HDAC inhibition is feasible in vivo.
- HDAC inhibitors offer a potential therapeutic strategy for preserving vision in patients with rod and cone dystrophies.
- These findings provide hope for maintaining vision in inherited retinal degeneration patients.
Related Concept Videos
Feedback Inhibition
Cancer Prevention
Some...
Enzyme Inhibition
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Inhibition of Cdk Activity

